Surgalign Holdings, Inc. lowered revenue guidance for 2022. The company is lowering its full year 2022 revenue outlook to be in the range of $82 to $84 million.
Surgalign Holdings, Inc.
Equities
SRGA
US86882C2044
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
-9.49% | 28.16B | |
+25.35% | 8.33B | |
+33.25% | 4.39B | |
-35.85% | 2.43B | |
-9.44% | 1.6B | |
-13.39% | 1.5B | |
-32.84% | 1.15B | |
+7.80% | 964M | |
-37.56% | 872M |